Research & Development: Page
-
PharmaVoice Team/PharmaVoice
Medicare Part D
Industry experts evaluate the impact of Medicare Part D and project what further market- shaping events are to come. For consumers, the implementation of Medicare Part D has mostly been positive — reduced out-of-pocket costs and improved access to medicines. According to a study by The Amundsen G...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
New Worlds of Opportunities Clinical Development
By Denise Myshko Technology will be the change agent for overhauling development processes to reduce costs and increase efficiencies. The development process needs to undergo a major overhaul to reduce costs and increase efficiencies to bring new medicines to market in a more timely manner. The c...
By Denise Myshko • Jan. 2, 2008 -
Explore the Trendlineâž”
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
What's New
What’s New New Healthcare-related Products, Services, and Companies CommonHealth Seeks to Enhance Healthcare with Launch of EvoLogue The agency is focusing on evolving the healthcare dialogue. CommonHealth Consumer Group (CCG) has launched EvoLogue, a full-service consumer agency providing insigh...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Doctors' Choice Awards
The doctors’ choice awards, an annual study conducted by the Association of Medical Media (formerly the Association of Medical Publications), is the only program that is voted on by the industry’s customers — the physicians. Winners are selected according to their scores in an independent Interne...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Delivering New Hope
In a bid to tackle patient compliance, improve treatments, and maximize drug sales, companies are increasingly looking to emerging drug delivery technologies. By Kim Ribbink Necessity is the mother of invention. In the pharmaceutical industry “necessity” might be characterized as patent expiratio...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Milestones In More than 1 Million Served InfoMedics Inc. recently reached a set of significant milestones, including the enrollment of the 1 millionth patient and 500,000th physician in the course of implementing more than 150 patient-physician communications programs for 14 of the top 15 pharmac...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
By Taren Grom, Editor I’m getting ready for Web. 2.0. Is your avatar up to date and ready to navigate the “new” World Wide Web? Web 2.0, social networking, or as the contributing author of this month’s Outlet refers to the recent phenomenon “the collective Web,” is seemingly on the tip of everyon...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Craig A. DeLarge Craig A. DeLarge discusses Web 2.0’s drawbacks and opportunities. January 2008 Web 2.0 — Opportunities and Drawbacks n the last month, I have been intensely researching the Web 2.0 phenomenon with respect to its healthcare manifestations. This research has involved...
By Craig A. DeLarge • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Human Resource Related Issues
Otuska America Pharmaceutical’s Lorraine Daly, Leslie Eggleston, and Richard Obring discuss how HR issues, including compliance, compensation, and staffing can impact a pharmaceutical company’s culture. Otsuka’s Human Resources Department is responsible for more than 600 Otsuka employees in the U...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
When the Stars Align
By Robin Robinson The practice of using celebrities in marketing campaigns has not lost its luster, but the pharma industry is more selective in choosing icons who match brand images. As the industry approaches the 10th anniversary of the FDA’s ruling to allow DTC and subsequently the industry’s ...
By Robin Robinson • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Pharmacists Could Impact $145 Billion in Drug Sales in Five Years One state, Florida, already allows pharmacists to independently prescribe prescription drugs, and new research suggests six other states may soon give pharmacists this pow...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Crystal Ball
Industry experts identify the top trends they expect to shape the industry. We asked our industry experts to identify the top trends that they expect to shape the industry in the coming year and beyond. Some of their responses may surprise you; others may already be on your radar. You may agree w...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The 7th Annual PharmaLinx Charity Golf Outing
We Extend Thanks to These Companies for Their Contributions GOLD CORPORATE SPONSORS Gallagher Benefits Services Inc. J. Knipper and Company Inc. SILVER CORPORATE SPONSORS D. Anderson & Co. InfoMedics Inc. BRONZE CORPORATE SPONSORS CommonHealth Proprint Hole And Prize SponSORs BPG Properties L...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Managed Markets: Military Healthcare
By Denise Myshko While there has been much focus on the federal government’s role with Medicare drug benefits, there are two other significant healthcare segments for which it is also responsible: veterans and military personnel. In 2005, the Department of Veterans Affairs (VA) spent $4.2 billion...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
In his 20 years in the biotechnology industry, Harvey J. Berger, M.D., has witnessed huge leaps in terms of scientific research as well as the development of an industry. Today, as Founder, Chairman, and CEO of Ariad Pharmaceuticals, Dr. Berger has been the driving force in taking the company to ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: The Learning Key Offers Tools for Learning about Partnerships The Learning Key has launched a game, Partnering Success: The Challenge, as a way to make learning fun and memorable. The business-based board game provides trai...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Interplay Between Adaptive Clinical Trials and E-Clinical Architecture
Medidata Solutions Worldwide The Interplay Between Adaptive Clinical Trials and E-Clinical Architecture A Coin Toss From Fair to Biased Hugh Levaux VP, Product Strategy About half of all Phase III clinical trials fail to prove the key clinical hypothesis under evaluation; the odds of ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
A new technology frontier By Taren Grom, Editor Letter from the Editor VIEW on E-Solutions October 2007 Social networks, second lives, virtual Websites, online videos, blogs, interactive communications — can it be that we are talking about the latest technologies for the pharmaceutical in...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Look at EDC Implementation
A Look at EDC Implementation clinicaL-trial Solutions VIEW on E-Solutions October 2007 Keep in mind that any journey begins with a single step. Gregory J. Bailey Director of Programming So you think that EDC is an over publicized topic? What more could possi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Future of Video in Healthcare Marketing
The Future of Video in Healthcare Marketing marketing solutions D S Simon Productions Inc. Douglas Simon President and CEO When the FDA approved Viagra in 1998, Pfizer’s video communication strategy featured a video news release. More than 200 million people saw that video, which helped ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
An international connection Internet and Physicians in Latin America As in the rest of the world, healthcare professionals from across Latin America use the Internet to be informed, and surprisingly, a majority use their free time to do so. A recent survey by Medimix International shows that most...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
On behalf of the PharmaLinx LLC family, I would like to thank all of those who contributed to the success of the 7th annual charity golf event. Seven years ago, believe it or not, we — Lisa Banket, Marah Walsh, and myself — not only founded the company and began publishing PharmaVOICE but establi...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Managed Markets: Workers' Comp Pharmacy Costs Rising
By Denise Myshko Total spend for drugs in the workers’ compensation arena is expected to be $5.5 billion in 2007 and represents 15% of total medical costs associated with workers’ compensation. This is the fastest growing component of the system’s medical expense. The use of generic drugs is sign...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Adaption Adoption
By Denise Myshko The double-blind, randomized, parallel group design of clinical trials is so entrenched with well-established processes and systems in the industry that to even consider a change in structure may seem like an uphill battle. But many in the pharmaceutical industry — from pharmaceu...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
PharmaVOICE 100 of the Most Inspiring People July/August 2007 Download PDF
By PharmaVoice Team • Jan. 2, 2008
Previous
